Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ScoliVit: Vitamin D in Adolescent Scoliosis
NCT03582917Phase 2Recruiting
- Sponsor
- University of Ioannina
- Start
- Sep 2018
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of alfacalcidol in adolescent idiopathic scoliosis (AIS) (2 arms), sponsored by University of Ioannina. Primary endpoints: Serum 25-hydroxyvitamin D levels at 48 weeks, Radiographic Cobb Angle at 48 weeks and 2 more. Started Sep 2018; status: recruiting.
02
Drugs
alfacalcidol
03
Conditions
adolescent idiopathic scoliosis (AIS)
Beyond the preview
Go deeper on NCT03582917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582917.